Comparison of the efficacy of pretreatment protection against adrenal necrosis induced by 7-hydroxymethyl-12-methylbenz(a)anthracene and by 7-methyl-12-methylbenz(a)anthracene in rats.
D000311:Adrenal Glands / Q000187:drug effects*; D000616:Aminoglutethimide / Q000627:therapeutic use; D000818:Animals; D001391:Azo Compounds / Q000627:therapeutic use; D001551:Benz(a)Anthracenes / Q000008:administration & dosage; D002746:Chlorpromazine / Q000627:therapeutic use; D004396:Coloring Agents / Q000627:therapeutic use; D003632:Dichlorodiphenyldichloroethane / Q000627:therapeutic use; D005260:Female; D005984:Glutethimide / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007441:Intubation, Gastrointestinal; D008748:Methylcholanthrene / Q000627:therapeutic use; D009336:Necrosis / Q000139:chemically induced / Q000188:drug therapy*; D010634:Phenobarbital / Q000627:therapeutic use; D011083:Polycyclic Compounds / Q000627:therapeutic use; D051381:Rats; D012964:Sodium / Q000627:therapeutic use; D013997:Time Factors; D004124:p-Dimethylaminoazobenzene / Q000627:therapeutic use
D001391:Azo Compounds; D001551:Benz(a)Anthracenes; D004396:Coloring Agents; D011083:Polycyclic Compounds; D000616:Aminoglutethimide; D008748:Methylcholanthrene; D012964:Sodium; D004124:p-Dimethylaminoazobenzene; D005984:Glutethimide; D002746:Chlorpromazine; D003632:Dichlorodiphenyldichloroethane; D010634:Phenobarbital